MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MEDNAX Company Profile (NYSE:MD)

Consensus Ratings for MEDNAX (NYSE:MD) (?)
Ratings Breakdown: 3 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $80.13 (19.71% upside)

Analysts' Ratings History for MEDNAX (NYSE:MD)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016MizuhoBoost Price TargetBuy$75.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Piper JaffrayReiterated RatingOverweight$76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/8/2016Stifel NicolausLower Price TargetBuy$81.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016SusquehannaDowngradePositive -> Neutral$94.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015StephensReiterated RatingEqual Weight$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015JPMorgan Chase & Co.Lower Price Target$94.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/20/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Dougherty & CoBoost Price TargetBuy$88.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Deutsche BankReiterated RatingBuy$77.00 -> $79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Raymond JamesBoost Price TargetOutperform$78.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2014SunTrustInitiated CoverageNeutral$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha